Baricitinib and β-Cell Function in Patients with New-Onset Type 1 Diabetes | NEJM
Original Article from The New England Journal of Medicine — Baricitinib and β-Cell Function in Patients with New-Onset Type 1 Diabetes
Original Article from The New England Journal of Medicine — Baricitinib and β-Cell Function in Patients with New-Onset Type 1 Diabetes
For Authors | JAMA | JAMA Network .brightcove-video {margin: 2em 0;} /* .brightcove-video .vjs-big-play-button.vjs-big-play-button {-webkit-transform: none;transform: none;} */ For Authors About JAMA Why Publish in…
One of the major determinants of exercise intolerance and limiting symptoms among patients with obstructive hypertrophic cardiomyopathy (HCM) is an elevated intracardiac pressure resulting from…
This first episode of the four-part Double Take video miniseries on depression empowers the primary care physician to screen for, diagnose, and address suicidality.
One of the major determinants of exercise intolerance and limiting symptoms among patients with obstructive hypertrophic cardiomyopathy (HCM) is an elevated intracardiac pressure resulting from…
Join us to read 1 paper per day and stay up-to-date as we cover the spectrum of critical care across 2023
In April 1964, leading cardiologists, cardiovascular surgeons, and pathologists convened in London for a 2-day symposium to discuss a relatively new disease entity that we…
Ghrelin’s intriguing phase 2 results need confirmation in larger phase 3 trials
Background Sepsis occurs in 12–27% of patients with haematological malignancy within a year of diagnosis. Sepsis mortality has improved in non-cancer patients in the last…